Microbiota Regulates Phosphatidylcholine in the Intestinal Mucus Lipidome of Mice in a Strain‐ and Segment‐Dependent Manner
Open Access
- 10 November 2026
- journal article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (6)
Abstract
Background: Type 1 diabetes (T1D) is associated with intestinal barrier dysfunction, which depends on an intact mucus layer. Phosphatidylcholine (PC) is a major lipid of intestinal mucus that likely exerts an important barrier function due to its hydrophobic and anti‐inflammatory properties. Recently, we showed that PC is reduced in jejunal and colonic mucus in pre‐diabetic non‐obese diabetic (NOD) mice compared to C57BL/6 (B6) mice. As such, PC may play a protective role in T1D. Some bacteria produce PC. However, it is unknown whether T1D‐associated dysbiosis (i.e., altered microbial composition) is behind the reduced PC content in the intestine. Methods: Here, we examined the impact of gut microbiota on jejunal and colonic mucus PC composition. This was done by treating 4 weeks old pre‐diabetic NOD and B6 mice with a broad‐spectrum antibiotic cocktail and by breeding germ‐free BALB/c mice, which were then compared with untreated barrier‐housed NOD, B6 and BALB/c mice. The intestinal mucus lipid profile was analysed by quantitative shotgun lipidomics, while the relative composition of the faecal microbiota was assessed by 16S rRNA gene amplicon sequencing and verified by absolute quantifications using qPCR. Results: Comparing jejunum and colon from the mice revealed that the overall intestinal mucus lipidome was segment‐ but not strain‐specific. Antibiotic treatment reduced colonic PC levels in the NOD and B6 mice, whereas germ‐free conditions did not in the BALB/c mice, which, independent of the presence of microbiota, had the lowest levels of colon PC. The faecal microbiome composition also differed between the three strains of untreated barrier‐housed mice, including reduced abundance of phyla with PC‐containing bacteria in the BALB/c mice. Conclusions: Results suggest that gut microbiota perturbation is an important determinant of intestinal mucus PC content, although the effect seems to depend on the host‐specific baseline microbiota composition.Funding Information
- Poul og Erna Sehested Hansens Fond
- Skibsreder Per Henriksen, R. og hustrus fond
This publication has 27 references indexed in Scilit:
- Gastrointestinal mucus in dog: Physiological characteristics, composition, and structural propertiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2022
- Physiological properties, composition and structural profiling of porcine gastrointestinal mucusEuropean Journal of Pharmaceutics and Biopharmaceutics, 2021
- Intestinal permeability in type 1 diabetes: An updated comprehensive overviewJournal of Autoimmunity, 2021
- Lipid-polymer nano core-shell type hybrid system for colon specific drug deliveryJournal of Drug Delivery Science and Technology, 2021
- Comprehensive Evaluation of a Quantitative Shotgun Lipidomics Platform for Mammalian Sample Analysis on a High-Resolution Mass SpectrometerJournal of the American Society for Mass Spectrometry, 2020
- The biology of mucus: Composition, synthesis and organizationAdvanced Drug Delivery Reviews, 2018
- Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetesNature Immunology, 2017
- LipidXplorer: Software for Quantitative Shotgun Lipidomics Compatible with Multiple Mass Spectrometry PlatformsCurrent Protocols in Bioinformatics, 2013
- Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cellsEuropean Journal of Immunology, 2012
- Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesisInflammatory Bowel Diseases, 2009